Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas

NCT: NCT03542409 · COMPLETED

NCT IDNCT03542409
StatusCOMPLETED
Start Date2017-02-15
Completion2025-05-14
SponsorUniversity of Utah (OTHER)
First posted
Last updated

Brief Summary

This study evaluates the use of specialized magnetic resonance imaging (MRI) techniques including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the surgical treatment of gliomas. Cohort 1 participants will undergo an MR perfusion scan or 2-HG spectroscopy prior to surgery and intra-operatively. Cohort 2 participants will only undergo standard of care imaging and tumor acquisition. Participant participation will end at the completion of surgery and will be transitioned to standard of care follow-up.

Frequently Asked Questions

What is Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas?

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas is a clinical trial registered under NCT03542409. Current status: COMPLETED.

What is the status of NCT03542409?

The current status of NCT03542409 (Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas) is: COMPLETED.

When did Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas start?

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas started on 2017-02-15.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.